| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | Coiante Scott M | SVP, Chief Financial Officer | Jun 03, 2022 | Option Exercise | $0.81 | 35,284 | 28,404 | 84,265 | Jun 07, 2022, 05:02 PM | |
| APRE | Aprea Therapeutics, Inc. | Coiante Scott M | SVP, Chief Financial Officer | Feb 25, 2022 | Option Exercise | $1.74 | 14,817 | 25,782 | 76,649 | Mar 01, 2022, 05:01 PM | |
| APRE | Aprea Therapeutics, Inc. | Coiante Scott M | SVP, Chief Financial Officer | Aug 25, 2021 | Option Exercise | $3.98 | 7,534 | 29,985 | 91,466 | Aug 27, 2021, 05:01 PM | |
| APRE | Aprea Therapeutics, Inc. | Coiante Scott M | SVP, Chief Financial Officer | Oct 07, 2019 | Buy | $15.00 | 2,500 | 37,500 | 2,500 | Oct 07, 2019, 07:15 PM | |
| AGRX | AGILE THERAPEUTICS INC | Coiante Scott M | Chief Financial Officer | Jan 25, 2018 | Option Exercise | $3.32 | 6,753 | 22,420 | 14,686 | Jan 26, 2018, 05:16 PM |
Menu